Legal briefings from the world's leading law firms
Legal Briefing
UK Supreme Court gives gene-patenting boost to bioinformatics industry
Practice Area: Life science
Sector: Business services
Jurisdiction: England & Wales
Published: 09 December 2011
Law Firm: Eversheds
Overview
In a surprise u-turn, the UK Supreme Court in HGS v Eli Lily overturned the Court of Appeal and Patents Court to uphold the validity of a patent for encoding nucleotide, the amino acid sequence, and certain antibodies of the human protein Neutrokine-a, which had been discovered through the use of bioinformatics.
In this briefing, Eversheds provides background information on bioinformatics, and outlines the original decision of the Court of Appeal and Patents Court and why the Supreme Court overturned it. Lastly, Eversheds comments as to why the Supreme Court's decision is a significant one for the UK biotech industry.
Click 'View Briefing' to read on.
Rating: 
2 people found this useful
People who read this also read these
- Exemption situation
- English patent court changing attitude towards making generics “clear the way”
- From sponsored links to cuckoo clocks - intellectual property update
- From imitation perfumes to aeroplane flat beds - ECJ cases
- How to handle IP assets in an insolvency
- Dyson blasts Samsung's vacuum cleaner patents
Keep up to date with the most recently added briefings to LegalWeekLaw.com
© Incisive Media Investments Limited 2012, Published by Incisive Financial Publishing Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 04252091 & 04252093.